KaliVir Immunotherapeutics
PrivateLast Round
Series A
Extension
Aug 19, 2026
Total Funding Raised
$29M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
KaliVir Immunotherapeutics is a biotechnology company developing next-generation oncolytic viral immunotherapy programs for the treatment of cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
KaliVir Immunotherapeutics Comparables
Compare KaliVir Immunotherapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Accession Therapeutics Limited | 87% | |
| Virogin Biotech | 86% | |
| TILT Biotherapeutics | 85% |
KaliVir Immunotherapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Aug 19, 2026 | ||||
| Series A | Mar 16, 2022 |
KaliVir Immunotherapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SV Investment | Series A Extension |
| Premier Partners | Series A |
| Nextrans | Series A Extension |
| QUAD Investment Management | Series A Extension, Series A |
| Company K Partners | Series A, Series A Extension |
| Company K Partners | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 19, 2026
$14M round with participation from QUAD Investment Management and SV Investment.
- Jan 23, 2026
Monthly visitors grew 95% MoM, reaching 1.6K.
Recent news
Latest coverage and updates
- receives_financingAug 19, 2026
KaliVir Immunotherapeutics, Inc. received financing of $14M in Series A1 on Aug 19th '26.
KaliVir Immunotherapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about KaliVir Immunotherapeutics's valuation, stock price, and market status.
Is KaliVir Immunotherapeutics a public or private company?
KaliVir Immunotherapeutics is a private company.
What is the current stock price of KaliVir Immunotherapeutics?
KaliVir Immunotherapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is KaliVir Immunotherapeutics worth (valuation)?
Valuation information for KaliVir Immunotherapeutics is not publicly available.
Can I buy KaliVir Immunotherapeutics stock?
KaliVir Immunotherapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was KaliVir Immunotherapeutics's last funding round?
KaliVir Immunotherapeutics's most recent funding round was Series A on March 16, 2022.
Who are the main investors in KaliVir Immunotherapeutics?
Key investors in KaliVir Immunotherapeutics include Premier Partners.
Will KaliVir Immunotherapeutics IPO soon?
No public IPO plans have been announced for KaliVir Immunotherapeutics.
How can I track KaliVir Immunotherapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor KaliVir Immunotherapeutics's secondary market activity and sign up for updates.